Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NNNN | XENE | SYRE | ||
| Company | Anbio Biotechnology Cl A | Xenon Pharmaceuticals Inc | Spyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 22.17 | 60.56 | 39.75 | ||
| High | 22.64 | 62.91 | 41.88 | ||
| Low | 21.63 | 58.00 | 39.21 | ||
| Latest | 22.21 | 62.76 | 41.07 | ||
| Change | -0.68 | +20.82 | +0.92 | ||
| % Change | -2.97% | +49.64% | +2.29% | ||
| Volume | 37,700 | 11,513,051 | 882,100 | ||
| 20-Day Average Volume | 66,245 | 1,477,078 | 803,012 | ||
| Previous Close | 22.89 | 41.94 | 40.15 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.51 | 43.84 | 39.48 | ||
| 20-Day Raw Stochastic | 11.92% | 99.32% | 65.03% | ||
| 20-Day Relative Strength | 44.75 | 78.95 | 60.51 | ||
| Weighted Alpha | -36.37 | +54.81 | +182.19 | ||
| Today's Opinion | 88% Sell | 100% Buy | 100% Buy | ||
| Previous Opinion | 88% Sell | 56% Buy | 100% Buy | ||
| Last Month's Opinion | 56% Sell | 24% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.06% since 03/02/26 | +47.50% since 03/02/26 | -3.34% since 03/02/26 | ||
| Low | 21.21 on 03/06/26 | 41.05 on 03/06/26 | 38.36 on 03/06/26 | ||
| High | 24.74 on 03/04/26 | 62.91 on 03/09/26 | 42.58 on 03/04/26 | ||
| 1-Month | |||||
| %Chg | -4.51% since 02/09/26 | +47.91% since 02/09/26 | +20.94% since 02/09/26 | ||
| Low | 21.21 on 03/06/26 | 40.74 on 02/11/26 | 32.35 on 02/11/26 | ||
| High | 30.49 on 02/27/26 | 62.91 on 03/09/26 | 45.76 on 02/23/26 | ||
| 3-Month | |||||
| %Chg | -34.19% since 12/09/25 | +44.21% since 12/09/25 | +21.94% since 12/09/25 | ||
| Low | 18.50 on 01/27/26 | 39.29 on 01/20/26 | 28.00 on 01/05/26 | ||
| High | 44.44 on 01/29/26 | 62.91 on 03/09/26 | 45.76 on 02/23/26 | ||
| 6-Month | |||||
| %Chg | -51.69% since 09/09/25 | +67.32% since 09/09/25 | +145.34% since 09/09/25 | ||
| Low | 10.50 on 11/04/25 | 35.60 on 09/15/25 | 14.51 on 09/22/25 | ||
| High | 51.33 on 10/03/25 | 62.91 on 03/09/26 | 45.76 on 02/23/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,293,665 | 3,488,989 | 3,153,381 | ||
| Shares Outstanding, K | 143,891 | 83,190 | 78,540 | ||
| Annual Sales | 8,190,000 | 7,500,000 | 0 | ||
| Annual Net Income | 2,370,000 | -345,910,000 | -155,200,000 | ||
| Last Quarter Sales | N/A | 0 | 0 | ||
| Last Quarter Net Income | N/A | -105,260,000 | -62,530,000 | ||
| 60-Month Beta | N/A | 0.91 | 3.09 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -1.31 on 02/26/26 | -0.15 on 11/04/25 | ||
| Latest Earnings Date | N/A | 05/11/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||